List of SBIR/STTR awards granted to Molecular Express Inc
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Molecular Express Inc in June, 2021 for $956,889.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44HL154968-01A1 | Phase II | 956,889 | June 18, 2021 | |||||||
A SBIR Phase I contract was awarded to Molecular Express Inc for $213,800.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 272201800053C-0-0-0 | Phase I | 213,800 | ||||||||
A SBIR Phase I contract was awarded to Molecular Express Inc in February, 2022 for $299,817.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI167312-01 | Phase I | 299,817 | February 18, 2022 | |||||||
A SBIR Phase I contract was awarded to Molecular Express Inc in July, 2022 for $298,479.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI167394-01 | Phase I | 298,479 | July 8, 2022 | |||||||
A SBIR Phase I contract was awarded to Molecular Express Inc for $299,993.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93020C00012 | Phase I | 299,993 | ||||||||
A SBIR Phase II contract was awarded to Molecular Express Inc for $1,994,571.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93021C00027 | Phase II | 1,994,571 | ||||||||
A SBIR Phase I contract was awarded to Molecular Express Inc for $599,983.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93019C00007 | Phase I | 599,983 | ||||||||
A SBIR Phase I contract was awarded to Molecular Express Inc for $299,961.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93020C00010 | Phase I | 299,961 | ||||||||
A SBIR Phase I contract was awarded to Molecular Express Inc for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93022C00012 | Phase I | 300,000 | ||||||||
A SBIR Phase I contract was awarded to Molecular Express Inc for $299,994.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93021C00027 | Phase I | 299,994 | ||||||||
A SBIR Phase I contract was awarded to Molecular Express Inc for $569,807.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93021C00039 | Phase I | 569,807 | ||||||||
A SBIR Phase II contract was awarded to Molecular Express Inc in August, 2016 for $1,499,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI094770-03A1 | Phase II | 1,499,000 | August 1, 2016 | |||||||
A SBIR Phase I contract was awarded to Molecular Express Inc in June, 2015 for $290,263.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI118123-01A1 | Phase I | 290,263 | June 15, 2015 | |||||||
A SBIR Phase II contract was awarded to Molecular Express Inc in July, 2017 for $1,431,794.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI115828-02 | Phase II | 1,431,794 | July 1, 2017 | |||||||
A SBIR Phase I contract was awarded to Molecular Express Inc in February, 2017 for $300,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI131788-01 | Phase I | 300,000 | February 7, 2017 | |||||||
A STTR Phase II contract was awarded to Molecular Express Inc in September, 2015 for $320,176.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R42DA040422-01 | Phase II | 320,176 | September 1, 2015 | |||||||
A SBIR Phase II contract was awarded to Molecular Express Inc in November, 2005 for $729,997.0 USD from the U.S. Department of Defense. | SBIR | W911NF-06-C-0036 | Phase II | 729,997 | November 11, 2005 | |||||||
A STTR Phase I contract was awarded to Molecular Express Inc in September, 2015 for $225,033.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R42DA040422-01 | Phase I | 225,033 | September 1, 2015 | |||||||
A SBIR Phase I contract was awarded to Molecular Express Inc in June, 2015 for $329,911.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI115828-01A1 | Phase I | 329,911 | June 15, 2015 | |||||||
A SBIR Phase I contract was awarded to Molecular Express Inc in April, 2016 for $225,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI124725-01 | Phase I | 225,000 | April 1, 2016 | |||||||
A STTR Phase I contract was awarded to Molecular Express Inc in September, 2015 for $322,946.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41TR001338-01 | Phase I | 322,946 | September 1, 2015 | |||||||
A SBIR Phase I contract was awarded to Molecular Express Inc in December, 2004 for $119,976.0 USD from the U.S. Department of Defense. | SBIR | W911NF-05-C-0015 | Phase I | 119,976 | December 7, 2004 | |||||||
A SBIR Phase I contract was awarded to Molecular Express Inc for $138,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL080775-01 | Phase I | 138,000 | ||||||||
A SBIR Phase I contract was awarded to Molecular Express Inc for $599,998.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI104073-01A1 | Phase I | 599,998 | ||||||||
A SBIR Phase II contract was awarded to Molecular Express Inc for $1,982,170.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI066621-03 | Phase II | 1,982,170 |
